Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Unexpected phase I results reported for DuP-532

Feb. 25, 1997

Deltibant in SIRS

Feb. 21, 1997

Cylexin enters clinical trials in newborns

Feb. 21, 1997

Novel vasopressin antagonists from Fujisawa

Feb. 21, 1997

Biorex discloses antiischemic agents

Feb. 20, 1997

Zambon discloses ACE/NEP inhibitors

Feb. 20, 1997

Antiarrhythmic agents from Merck & Co.

Feb. 19, 1997

German launch for ACE inhibitor

Feb. 17, 1997

Approval anticipated for TMR using Heart Laser

Feb. 14, 1997

Zeneca describes ET antagonists

Feb. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...